Literature DB >> 23567339

Building blood vessels in development and disease.

Erich J Kushner1, Victoria L Bautch.   

Abstract

PURPOSE OF REVIEW: This review will examine developmental angiogenesis and tumor-related changes to endothelial cells. RECENT
FINDINGS: Processes that govern developmental angiogenesis become dysfunctional in the tumor environment, leading to abnormal tumor endothelial cells and blood vessels. Recent findings suggest that tumor endothelial cells are permanently modified compared with normal counterparts.
SUMMARY: Coordination of numerous intracellular and extracellular programs promotes the formation of new blood vessels that are necessary for both development and certain diseases. Developmental angiogenesis uses canonical signaling modalities to effectively assemble endothelial cells into predictable vessel structures, and disruption of critical signaling factors has dramatic effects on blood vessel development. Solid tumors co-opt developmental cues to promote formation of tumor vessels that sustain their growth, but these angiogenic signals are not well regulated and produce endothelial cell dysfunction. Aberrant growth factor signaling contributes to phenotypic changes and acquired irreversible intracellular signaling, cytoskeletal and genetic modifications in endothelial cells of tumor vessels. Permanently altered tumor endothelial cells may represent a significant population.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23567339     DOI: 10.1097/MOH.0b013e328360614b

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  27 in total

1.  Role of five small nucleotide polymorphisms in the VEGF gene on the susceptibility to osteosarcoma and overall survival of patients.

Authors:  Jian-Qiang Liu; Xia Bai; DE-Chen Duan; Ai-Xia Dou
Journal:  Oncol Lett       Date:  2015-06-19       Impact factor: 2.967

Review 2.  Diversity is in my veins: role of bone morphogenetic protein signaling during venous morphogenesis in zebrafish illustrates the heterogeneity within endothelial cells.

Authors:  Jun-Dae Kim; Heon-Woo Lee; Suk-Won Jin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-07-24       Impact factor: 8.311

3.  Predictive value of vascular endothelial growth factor polymorphisms on the risk of renal cell carcinomas: a case-control study.

Authors:  Guangjian Lu; Yuqian Dong; Qunmei Zhang; Luyang Jiao; Shujuan Yang; Beili Shen
Journal:  Tumour Biol       Date:  2015-06-05

4.  Single nucleotide polymorphisms in VEGF gene are associated with an increased risk of osteosarcoma.

Authors:  Zhang Tie; Rui Bai; Zhongwen Zhai; Gang Zhang; Hong Zhang; Zhenqun Zhao; Deshan Zhou; Wanlin Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

5.  Association of the vascular endothelial growth factor (VEGF) gene single-nucleotide polymorphisms with osteosarcoma susceptibility in a Chinese population.

Authors:  Zhen Wang; Peng Wen; Xiaojun Luo; Xiaomin Fang; Qingfeng Wang; Feng Ma; Jinhan Lv
Journal:  Tumour Biol       Date:  2013-12-06

6.  Potential lung carcinogenicity induced by chronic exposure to PM2.5 in the rat.

Authors:  Xiaoli Hu; Qingzhao Li; Shifeng Shao; Qiang Zeng; Shoufang Jiang; Qi Wu; Chunyang Jiang
Journal:  Environ Sci Pollut Res Int       Date:  2017-06-28       Impact factor: 4.223

Review 7.  The pathogenic role of angiogenesis in rheumatoid arthritis.

Authors:  Hatem A Elshabrawy; Zhenlong Chen; Michael V Volin; Shalini Ravella; Shanti Virupannavar; Shiva Shahrara
Journal:  Angiogenesis       Date:  2015-07-22       Impact factor: 9.596

8.  Genetic modification of corneal neovascularization in Dstn (corn1) mice.

Authors:  Sharolyn V Kawakami-Schulz; Shannon G Sattler; Anna-Lisa Doebley; Akihiro Ikeda; Sakae Ikeda
Journal:  Mamm Genome       Date:  2013-08-09       Impact factor: 2.957

Review 9.  Platelets and cancer: a casual or causal relationship: revisited.

Authors:  David G Menter; Stephanie C Tucker; Scott Kopetz; Anil K Sood; John D Crissman; Kenneth V Honn
Journal:  Cancer Metastasis Rev       Date:  2014-03       Impact factor: 9.264

Review 10.  Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance.

Authors:  Shizhu Chen; Keni Yang; Ruslan G Tuguntaev; Anbu Mozhi; Jinchao Zhang; Paul C Wang; Xing-Jie Liang
Journal:  Nanomedicine       Date:  2015-12-17       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.